The OpenSSL Corporation and the OpenSSL Foundation are proud to announce the OpenSSL Conference 2025, taking place from October 7 to 9, 2025, in Prague, Czech Republic, at the Vienna House by Wyndham ...

Jonathan Porter, former Chief Product Officer, has been promoted to Chief Executive Officer of the company. With the ...

Biopharmaceutics, DPD, MDS, GSK, Ware SG12 0DP, U.K.

GSK exited Kenya in 2023 as part of its restructuring and now supplies its medicines and vaccines through a third-party distributor. Be part of an exclusive group of enthusiasts! Get fresh content ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other most undervalued biotech stocks to invest in. On February 21, Jared Holz, Mizuho Securities ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

GSK has garnered FDA approval for its pentavalent meningococcal vaccine Penmenvy, tipped as one of its major launches for 2025 and a rival to Pfizer's first-to-market Penbraya. The shot protects ...

In its effort to rival GSK’s shingles vaccine Shingrix, Curevo Vaccine has circled up $110 million and recruited two former GSK leaders to its board. The biotech’s series B was led by new ...